نتایج جستجو برای: hes 130

تعداد نتایج: 33487  

ژورنال: :مجله دانشکده پزشکی اصفهان 0
محمد رضا نیک کار متخصص بیهوشی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران محمد گل پرور دانشیار، گروه بیهوشی و مراقبت های ویژه، دانشکده ی پزشکی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران

مقدمه: کلوییدها در مایع درمانی بیماران نقش بسزایی دارند، ولی این محلول ها اثرات سویی بر روی سیستم انعقادی می گذارند که باعث محدودیت در استفاده از آن ها می شود. به تازگی انواع جدیدی از این محلول ها در دسترس قرار گرفته اند که اثرات سوء انعقادی کمتری برای آن ها ذکر شده است. هدف از این مطالعه، بررسی اثرات انعقادی انواع جدید در مقایسه با انواع قدیمی بود. روش ها: در یک کارآزمایی بالینی دوسوکور 58 بیم...

Journal: :British journal of anaesthesia 2008
J Boldt Ch Brosch K Röhm M Papsdorf A Mengistu

BACKGROUND The effects of hydroxyethylstarch (HES) 130/0.4 6% and gelatin 4% on inflammation, endothelial integrity, and renal function after cardiac surgery were compared. METHODS Sixty patients aged >80 yr undergoing cardiac surgery were randomized to receive gelatin (n=30) or HES 130/0.4 (n=30). The colloid was used in the priming of the cardiopulmonary bypass circuit (500 ml) and for volu...

Journal: :British journal of anaesthesia 2009
J Boldt S Suttner C Brosch A Lehmann A Mengistu

BACKGROUND This study compared the effects of a potato-based hydroxyethyl starch (HES) with those of a maize-derived HES preparation on coagulation in cardiac surgery patients. METHODS Sixty patients undergoing elective cardiac surgery with cardiopulmonary bypass were allocated randomly to receive either a potato-derived HES (6% HES 130/0.42) (n=30) or a waxy-maize-derived HES (6% HES 130/0.4...

Journal: :Paediatric anaesthesia 2012
Robert Sümpelmann Franz-Josef Kretz Robert Luntzer Thomas G de Leeuw Vladimir Mixa Ralf Gäbler Christoph Eich Markus W Hollmann Wilhelm A Osthaus

INTRODUCTION Third-generation hydroxyethyl starch (HES) is now approved also for the use in children, but safety studies including large numbers of pediatric patients are still missing. Therefore, we performed an European multicentric prospective observational postauthorization safety study (PASS) to evaluate the use of HES 130/0.42/6:1 in normal saline (ns-HES) or a balanced electrolyte soluti...

Journal: :Brazilian journal of anesthesiology 2013
Adilson Hamaji Ludhmila Hajjar Marcelo Caiero Juliano Almeida Rosana Ely Nakamura Eduardo A Osawa Julia Fukushima Filomena R Galas Jose Otavio Costa Auler Junior

BACKGROUND AND OBJECTIVES Hydroxyethyl starch (HES) 130/0.4 is considered an effective plasma expander when compared to crystalloids. There is controversy around its superiority regarding hemodynamic optimization and about possible detrimental effects on coagulation. The aim of this study was to compare the effects of HES 130/0.4 to lactated Ringer solution during hip arthroplasty in adult pati...

2013
Carlos A Estrada Raghavan Murugan

CITATION Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J; 6S Trial Group; Scan...

Journal: :The New England journal of medicine 2012
Anders Perner Nicolai Haase Anne B Guttormsen Jyrki Tenhunen Gudmundur Klemenzson Anders Åneman Kristian R Madsen Morten H Møller Jeanie M Elkjær Lone M Poulsen Asger Bendtsen Robert Winding Morten Steensen Pawel Berezowicz Peter Søe-Jensen Morten Bestle Kristian Strand Jørgen Wiis Jonathan O White Klaus J Thornberg Lars Quist Jonas Nielsen Lasse H Andersen Lars B Holst Katrin Thormar Anne-Lene Kjældgaard Maria L Fabritius Frederik Mondrup Frank C Pott Thea P Møller Per Winkel Jørn Wetterslev

BACKGROUND Hydroxyethyl starch (HES) [corrected] is widely used for fluid resuscitation in intensive care units (ICUs), but its safety and efficacy have not been established in patients with severe sepsis. METHODS In this multicenter, parallel-group, blinded trial, we randomly assigned patients with severe sepsis to fluid resuscitation in the ICU with either 6% HES 130/0.42 (Tetraspan) or Rin...

Journal: :Anesthesiology 2013
Richard B Weiskopf

1249 December 2013 D URING the past year, there has been substantial discussion about hydroxyethyl starches (HESs), with some claiming that neither efficacy nor safety has been demonstrated. In this issue of ANEStHESIoloGy, Van der linden et al.1 report a clinical efficacy trial with HES 130/0.4 that has several interesting issues. Some, but not all, are discussed relatively briefly, as space l...

2009
H. Heinze K. Hage F. Hackmann R. Schäfer R. Zulkowski K.-F. Klotz

Purpose: Different hydroxyethyl starches (HES) may lead to different volume effects. We compared a new HES130/0.42 with an established HES200/0.5 with respect to perioperative volume requirements, hemodynamic effects, safety and tolerability. Methods: After approval of the local ethics committee we investigated in a prospective, randomized double-blinded clinical trial 100 adult patients schedu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید